RENAL-TRANSPLANTATION FOR PATIENTS WITH TYPE-I AND TYPE-II MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS - SERIAL COMPLEMENT AND NEPHRITIC FACTOR MEASUREMENTS AND THE PROBLEM OF RECURRENCE OF DISEASE

被引：40
|
作者：
CURTIS, JJ
WYATT, RJ
BHATHENA, D
LUCAS, BA
HOLLAND, NH
LUKE, RG
机构：
[1] UNIV KENTUCKY,MED CTR,DEPT MED,LEXINGTON,KY 40506
[2] UNIV KENTUCKY,MED CTR,DEPT PATHOL,LEXINGTON,KY 40506
[3] UNIV KENTUCKY,MED CTR,DEPT PEDIAT,LEXINGTON,KY 40506
[4] UNIV KENTUCKY,MED CTR,DEPT SURG,LEXINGTON,KY 40506
来源：
AMERICAN JOURNAL OF MEDICINE | 1979年 / 66卷 / 02期
关键词：
D O I：
10.1016/0002-9343(79)90530-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：216 / 225
页数：10
相关论文
共 38 条
  • [31] SEROPREVALENCE OF HUMAN LYMPHOTROPIC-T VIRUS TYPE-I OR TYPE-II IN SEXUALLY-TRANSMITTED DISEASE CLINIC PATIENTS IN THE USA
    KHABBAZ, RF
    DOUGLAS, JM
    JUDSON, FN
    SPIEGEL, RA
    STLOUIS, ME
    WHITTINGTON, W
    HARTLEY, TM
    LAIRMORE, M
    KAPLAN, JE
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) : 241 - 244
  • [32] Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)
    Abrera-Abeleda, M. A.
    Nishimura, C.
    Smith, J. L. H.
    Sethi, S.
    McRae, J. L.
    Murphy, B. F.
    Silvestri, G.
    Skerka, C.
    Jozsi, M.
    Zipfel, P. F.
    Hageman, G. S.
    Smith, R. J. H.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 (07) : 582 - 589
  • [33] BONE ALKALINE-PHOSPHATASE (BAP) AND THE CARBOXY-TERMINAL PROPETIDE OF TYPE-I PROCOLLAGEN (PICP) IN PATIENTS FOLLOWING RENAL-TRANSPLANTATION
    WITHOLD, W
    DEGENHARDT, S
    GRABENSEE, B
    REINAUER, H
    CLINICAL CHEMISTRY, 1995, 41 (06) : S44 - S45
  • [34] INCREASED PLASMA-CONCENTRATIONS FOR TYPE-I AND TYPE-II TUMOR-NECROSIS-FACTOR RECEPTORS AND IL-2 RECEPTORS IN CANCER-PATIENTS
    ELSASSERBEILE, U
    GALLATI, H
    WEBER, W
    WILD, ED
    MONTING, JS
    VONKLEIST, S
    TUMOR BIOLOGY, 1994, 15 (01) : 17 - 24
  • [35] Kidney transplantation on patients having diabetes mellitus type I (IDDM) and diabetes mellitus type II (NIDDM) with end-stage renal disease (ESRD)
    Baptista, C
    Bastos, M
    Gomes, L
    Macario, F
    Rodrigues, D
    Alves, R
    Gomes, H
    Ferreira, C
    Roseiro, A
    Paiva, S
    Barros, L
    Ruas, L
    Carvalheiro, M
    Mota, A
    Furtado, L
    Ruas, M
    DIABETOLOGIA, 1997, 40 : 2124 - 2124
  • [36] Interleukin-6 and Soluble Tumor Necrosis Factor Receptors Type I and Type II correlate with Chronic Renal Insufficiency in patients with Coronary Artery Disease
    Syros, George
    Rabbani, Leroy
    Mehran, Roxana
    Chen, Hong Jun
    Morales, Andy
    Dangas, George D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A) : 81D - 81D
  • [37] COMPARISON BETWEEN SERUM LEVELS OF BONE ALKALINE-PHOSPHATASE AND THE CARBOXY-TERMINAL PROPEPTIDE OF TYPE-I PROCOLLAGEN AS MARKERS OF BONE-FORMATION IN PATIENTS FOLLOWING RENAL-TRANSPLANTATION
    WITHOLD, W
    DEGENHARDT, S
    GRABENSEE, B
    REINAUER, H
    CLINICA CHIMICA ACTA, 1995, 239 (02) : 143 - 151
  • [38] EFFECT OF SIMULTANEOUS PANCREAS AND KIDNEY-TRANSPLANTATION (SPK) ON QUALITY-OF-LIFE (QL) IN TYPE-I DIABETIC-PATIENTS WITH END-STAGE RENAL-DISEASE (ESRD)
    KIEBERT, G
    VANOOSTERHOUT, E
    VANBRONSWIJK, H
    GOOSZEN, H
    DIABETES, 1993, 42 : A258 - A258
1234